US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ImmunityBio, Inc.

9.91

+0.16001.64%

Post-market: 9.89-0.0246-0.25%17:01 EDT

Volume:10.45M

Turnover:102.11M

Market Cap:10.50B

PE:-10.02

High:10.05

Open:9.63

Low:9.43

Close:9.75

52wk High:12.43

52wk Low:1.95

Shares:1.06B

Float Shares:407.00M

Volume Ratio:0.59

T/O Rate:2.57%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.9887

EPS(LYR):-0.3820

ROE:78.05%

ROA:-30.54%

PB:-10.04

PE(LYR):-25.94

Loading ...

Overview Company News Filings

ImmunityBio survey shows UK NMIBC patients favor bladder-sparing therapy after BCG failure

ImmunityBio says ANKTIVA plus BCG shows lower cost per sustained responder vs TAR-200

Is ANKTIVA’s BCG Tie-Up And New Patents Altering The Investment Case For ImmunityBio (IBRX)?

Simply Wall St.

Movement Alert｜ImmunityBio Falls 7.89% in Regular Trading, Profit-Taking Emerges After Multiple Catalysts Priced In

ImmunityBio faces securities class action after FDA flags misleading Anktiva cancer claims

Movement Alert｜ImmunityBio Rises 5.03% in Regular Trading, Positive Clinical Data and Patent Grants Fuel Rally

Mink Therapeutics starts Phase 2 trial of agenT-797 in severe acute lung injury

S&P 500 Futures Rise In Premarket Trading; Immunovant, ImmunityBio Lead

ImmunityBio Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

ImmunityBio's Supplemental Biologics License Application for Anktiva Accepted by FDA

MT Newswires Live

ImmunityBio announces FDA acceptance of supplemental BLA for ANKTIVA

FDA accepts ImmunityBio sBLA for ANKTIVA plus BCG in papillary NMIBC

Immunitybio Announces FDA Acceptance of Supplemental Bla for Anktiva® Plus Bcg in Bcg-Unresponsive Non-Muscle Invasive Bladder Cancer With Papillary Disease; Pdufa Date Set for January 6, 2027

THOMSON REUTERS

Immunitybio Presents Favorable Comparative Effectiveness Data in Complete Response Rates of Nai + Bcg Versus Nadofaragene and Tar-200 at Aua 2026

THOMSON REUTERS

ImmunityBio reports higher complete response rates for ANKTIVA plus BCG in AUA analysis

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Amid Stalled Iran Peace Efforts, Inflation Concerns

MT Newswires Live

BRIEF-Immunitybio Announces Comprehensive U.S. Patents Covering Combination Of Anktiva With Bcg For Cancer Treatment

ImmunityBio Secures Five US Patents for Cancer Treatment

MT Newswires Live

ImmunityBio wins five US patents for ANKTIVA-BCG cancer treatment combo through 2035

Immunitybio Inc - Patents Cover Anktiva Plus Bcg for Bladder Cancer With Terms Through at Least 2035

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/IBRX/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRX\",,,,,undefined,":{"symbol":"IBRX","market":"US","secType":"STK","nameCN":"ImmunityBio, Inc.","latestPrice":9.91,"timestamp":1791489600000,"preClose":9.75,"halted":0,"volume":10445810,"hourTrading":{"tag":"盘后","latestPrice":9.8854,"preClose":9.91,"latestTime":"17:01 EDT","volume":53398,"amount":529145.9591570001,"timestamp":1791493278240,"change":-0.0246,"changeRate":-0.002482,"amplitude":0.019173},"delay":0,"changeRate":0.016410256410256424,"floatShares":407000000,"shares":1059836273,"eps":-0.988661,"marketStatus":"Post-Mkt","change":0.16,"latestTime":"10-08 17:01:23 EDT","open":9.63,"high":10.045,"low":9.43,"amount":102114561.63488,"amplitude":0.063077,"askPrice":9.99,"askSize":100,"bidPrice":9.86,"bidSize":328,"shortable":3,"etf":0,"ttmEps":-0.988661,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791504000000},"marketStatusCode":4,"adr":0,"listingDate":1438056000000,"exchange":"NASDAQ","adjPreClose":9.75,"preHourTrading":{"tag":"盘前","latestPrice":9.68,"preClose":9.75,"latestTime":"09:29 EDT","volume":38274,"amount":368701.747458,"timestamp":1791466150766,"change":-0.07,"changeRate":-0.007179,"amplitude":0.017436},"postHourTrading":{"tag":"盘后","latestPrice":9.8854,"preClose":9.91,"latestTime":"17:01 EDT","volume":53398,"amount":529145.9591570001,"timestamp":1791493278240,"change":-0.0246,"changeRate":-0.002482,"amplitude":0.019173},"volumeRatio":0.58619,"impliedVol":1.0308,"impliedVolPercentile":0.498},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRX\",,,,,undefined,":{"symbol":"IBRX","floatShares":407000000,"roa":"-30.54%","roe":"78.05%","lyrEps":-0.382011,"volumeRatio":0.58619,"shares":1059836273,"dividePrice":0,"high":10.045,"amplitude":0.063077,"preClose":9.75,"low":9.43,"week52Low":1.95,"pbRate":"-10.04","psRate":"63.35","week52High":12.43,"institutionHeld":0,"latestPrice":9.91,"committee":0.53271,"eps":-0.988661,"divideRate":0,"volume":10445810,"delay":0,"ttmEps":-0.988661,"open":9.63,"prevYearClose":1.98,"prevWeekClose":10.285,"prevMonthClose":9.44,"prevQuarterClose":9.44,"fiveDayClose":9.28,"twentyDayClose":7.72,"sixtyDayClose":7.73},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"IBRX","fiscalQuarterEnding":"2026/06","expectedEps":-0.09,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"pre","actualEps":-0.08},{"market":"US","date":"2026-05-07","symbol":"IBRX","fiscalQuarterEnding":"2026/03","expectedEps":-0.08,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.09},{"market":"US","date":"2026-02-23","symbol":"IBRX","fiscalQuarterEnding":"2025/12","expectedEps":-0.08,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1771822800000,"reportTimeType":"pre","actualEps":-0.06},{"market":"US","date":"2025-11-04","symbol":"IBRX","fiscalQuarterEnding":"2025/09","expectedEps":-0.1,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2025-08-05","symbol":"IBRX","fiscalQuarterEnding":"2025/06","expectedEps":-0.1,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-0.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1747800000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IBRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IBRX","date":"2026-10-07","current":-9.861823,"percent":0.091498,"low":-33.7927,"twenty":-7.993654,"median":-5.932507,"eighty":-4.054835,"high":-1.243325,"avg":-6.768391,"sd":4.555258,"marketCap":10269813485},"quantilePoints":[{"date":"2021-10-08","current":-11.438312,"twenty":-49.401306,"median":-20.674209,"eighty":-14.190778,"marketCap":3446088879},{"date":"2021-10-15","current":-12.074495,"twenty":-33.065373,"median":-20.245916,"eighty":-13.884371,"marketCap":3637755570},{"date":"2021-10-22","current":-10.737212,"twenty":-32.675027,"median":-19.832142,"eighty":-13.217028,"marketCap":3234864362},{"date":"2021-10-29","current":-10.165946,"twenty":-32.443583,"median":-19.222369,"eighty":-12.991118,"marketCap":3062755496},{"date":"2021-11-05","current":-10.905996,"twenty":-31.714708,"median":-18.380301,"eighty":-12.856091,"marketCap":3285714709},{"date":"2021-11-12","current":-9.494002,"twenty":-31.087485,"median":-17.102681,"eighty":-12.653551,"marketCap":3069429810},{"date":"2021-11-19","current":-7.907569,"twenty":-30.773023,"median":-16.594537,"eighty":-12.500348,"marketCap":2556532860},{"date":"2021-11-26","current":-7.993654,"twenty":-30.358617,"median":-16.492909,"eighty":-12.401675,"marketCap":2584364477},{"date":"2021-12-03","current":-7.181991,"twenty":-29.861331,"median":-16.311429,"eighty":-12.035545,"marketCap":2321952084},{"date":"2021-12-10","current":-7.218885,"twenty":-29.422753,"median":-16.246096,"eighty":-11.682398,"marketCap":2333879920},{"date":"2021-12-17","current":-8.042846,"twenty":-28.697544,"median":-16.188022,"eighty":-11.225385,"marketCap":2600268258},{"date":"2021-12-23","current":-8.79302,"twenty":-28.238245,"median":-16.035578,"eighty":-10.989089,"marketCap":2842800925},{"date":"2021-12-31","current":-7.481003,"twenty":-27.571744,"median":-15.810544,"eighty":-10.745002,"marketCap":2418623094},{"date":"2022-01-07","current":-7.70248,"twenty":-27.264394,"median":-15.708914,"eighty":-10.199703,"marketCap":2490227067},{"date":"2022-01-14","current":-8.206955,"twenty":-27.001937,"median":-15.320327,"eighty":-9.686872,"marketCap":2653325006},{"date":"2022-01-21","current":-6.66892,"twenty":-26.228381,"median":-14.800994,"eighty":-8.79302,"marketCap":2156075192},{"date":"2022-01-28","current":-6.361313,"twenty":-25.755651,"median":-14.736077,"eighty":-8.571657,"marketCap":2056625229},{"date":"2022-02-04","current":-6.632007,"twenty":-25.537875,"median":-14.632211,"eighty":-8.067442,"marketCap":2144141196},{"date":"2022-02-11","current":-7.333351,"twenty":-25.479802,"median":-14.411494,"eighty":-7.973174,"marketCap":2370887111},{"date":"2022-02-18","current":-9.117472,"twenty":-25.421728,"median":-14.099894,"eighty":-7.973174,"marketCap":2947696895},{"date":"2022-02-25","current":-8.465345,"twenty":-25.32881,"median":-13.905144,"eighty":-7.972351,"marketCap":2736862974},{"date":"2022-03-04","current":-6.987741,"twenty":-25.035435,"median":-13.333878,"eighty":-7.903464,"marketCap":2423278818},{"date":"2022-03-11","current":-6.895948,"twenty":-24.773455,"median":-13.217028,"eighty":-7.812412,"marketCap":2391445927},{"date":"2022-03-18","current":-6.792681,"twenty":-24.678386,"median":-13.015786,"eighty":-7.748491,"marketCap":2355633925},{"date":"2022-03-25","current":-6.586147,"twenty":-24.202182,"median":-12.983328,"eighty":-7.674619,"marketCap":2284009920},{"date":"2022-04-01","current":-6.666466,"twenty":-23.969888,"median":-12.853495,"eighty":-7.623044,"marketCap":2311863700},{"date":"2022-04-08","current":-5.909174,"twenty":-23.778245,"median":-12.684711,"eighty":-7.515551,"marketCap":2049242350},{"date":"2022-04-14","current":-5.794432,"twenty":-23.397862,"median":-12.645761,"eighty":-7.486065,"marketCap":2009451236},{"date":"2022-04-22","current":-4.853554,"twenty":-23.110398,"median":-12.554878,"eighty":-7.380274,"marketCap":1683164105},{"date":"2022-04-29","current":-4.165107,"twenty":-22.93908,"median":-12.438028,"eighty":-7.213631,"marketCap":1444417423},{"date":"2022-05-06","current":-4.245426,"twenty":-22.817126,"median":-12.262753,"eighty":-7.146326,"marketCap":1472271203},{"date":"2022-05-13","current":-3.75368,"twenty":-22.706787,"median":-12.074495,"eighty":-7.037365,"marketCap":1388869099},{"date":"2022-05-20","current":-4.205412,"twenty":-22.474492,"median":-11.905712,"eighty":-6.99361,"marketCap":1556010939},{"date":"2022-05-27","current":-4.216168,"twenty":-22.340922,"median":-11.594112,"eighty":-6.929147,"marketCap":1559990507},{"date":"2022-06-03","current":-3.925768,"twenty":-22.23639,"median":-11.373395,"eighty":-6.882179,"marketCap":1452542181},{"date":"2022-06-10","current":-3.646125,"twenty":-22.079591,"median":-11.133204,"eighty":-6.774323,"marketCap":1349073423},{"date":"2022-06-17","current":-3.409503,"twenty":-22.018614,"median":-10.970912,"eighty":-6.667448,"marketCap":1261522935},{"date":"2022-06-24","current":-4.4743,"twenty":-21.908273,"median":-10.776162,"eighty":-6.595319,"marketCap":1655500129},{"date":"2022-07-01","current":-4.291456,"twenty":-21.670172,"median":-10.685279,"eighty":-6.508123,"marketCap":1587847480},{"date":"2022-07-08","current":-5.141143,"twenty":-21.646943,"median":-10.425612,"eighty":-6.414035,"marketCap":1902233322},{"date":"2022-07-15","current":-4.839989,"twenty":-21.109762,"median":-10.152963,"eighty":-6.115708,"marketCap":1790805429},{"date":"2022-07-22","current":-4.700167,"twenty":-21.080725,"median":-9.84705,"eighty":-5.794432,"marketCap":1739071049},{"date":"2022-07-29","current":-4.183901,"twenty":-20.979096,"median":-9.265123,"eighty":-5.656743,"marketCap":1548051804},{"date":"2022-08-05","current":-4.829233,"twenty":-20.964577,"median":-9.105168,"eighty":-5.048614,"marketCap":1786825861},{"date":"2022-08-12","current":-4.808304,"twenty":-20.732283,"median":-8.780722,"eighty":-4.926033,"marketCap":1809374559},{"date":"2022-08-19","current":-4.223223,"twenty":-20.732283,"median":-8.678425,"eighty":-4.850856,"marketCap":1589207300},{"date":"2022-08-26","current":-4.350877,"twenty":-20.674209,"median":-8.625301,"eighty":-4.818477,"marketCap":1637243793},{"date":"2022-09-02","current":-4.563634,"twenty":-20.369323,"median":-8.440736,"eighty":-4.755115,"marketCap":1717304614},{"date":"2022-09-09","current":-4.935958,"twenty":-20.322864,"median":-8.192539,"eighty":-4.75273,"marketCap":1857411051},{"date":"2022-09-16","current":-6.446532,"twenty":-20.206717,"median":-8.067442,"eighty":-4.789157,"marketCap":2425842882},{"date":"2022-09-23","current":-5.138077,"twenty":-20.029592,"median":-8.012101,"eighty":-4.80566,"marketCap":1933468831},{"date":"2022-09-30","current":-5.287007,"twenty":-19.864082,"median":-7.969059,"eighty":-4.807709,"marketCap":1989511406},{"date":"2022-10-07","current":-5.446575,"twenty":-19.565004,"median":-7.897307,"eighty":-4.808188,"marketCap":2049557022},{"date":"2022-10-14","current":-5.255094,"twenty":-19.474989,"median":-7.850131,"eighty":-4.816442,"marketCap":1977502283},{"date":"2022-10-21","current":-5.648694,"twenty":-19.074281,"median":-7.792746,"eighty":-4.827082,"marketCap":2125614802},{"date":"2022-10-28","current":-6.169948,"twenty":-18.708418,"median":-7.759994,"eighty":-4.837838,"marketCap":2321763814},{"date":"2022-11-04","current":-5.350834,"twenty":-18.432567,"median":-7.688187,"eighty":-4.840172,"marketCap":2013529653},{"date":"2022-11-11","current":-5.850129,"twenty":-18.345457,"median":-7.66161,"eighty":-4.840172,"marketCap":2337775979},{"date":"2022-11-18","current":-5.279141,"twenty":-17.384339,"median":-7.630866,"eighty":-4.848728,"marketCap":2109602638},{"date":"2022-11-25","current":-5.349262,"twenty":-17.09397,"median":-7.608235,"eighty":-4.852475,"marketCap":2137623926},{"date":"2022-12-02","current":-6.240806,"twenty":-16.823928,"median":-7.515551,"eighty":-4.858322,"marketCap":2493894580},{"date":"2022-12-09","current":-6.160667,"twenty":-16.623574,"median":-7.491373,"eighty":-4.90022,"marketCap":2461870251},{"date":"2022-12-16","current":-6.597676,"twenty":-16.559693,"median":-7.481003,"eighty":-4.931988,"marketCap":2636503896},{"date":"2022-12-23","current":-5.593682,"twenty":-16.510331,"median":-7.374505,"eighty":-4.942341,"marketCap":2235296781},{"date":"2022-12-30","current":-5.194133,"twenty":-16.440643,"median":-7.306863,"eighty":-4.940213,"marketCap":2075632726},{"date":"2023-01-06","current":-4.436015,"twenty":-16.359339,"median":-7.212318,"eighty":-4.866558,"marketCap":1772680414},{"date":"2023-01-13","current":-4.897033,"twenty":-16.333207,"median":-7.171327,"eighty":-4.842346,"marketCap":1956908171},{"date":"2023-01-20","current":-4.722871,"twenty":-16.275133,"median":-7.124178,"eighty":-4.829233,"marketCap":1887311019},{"date":"2023-01-27","current":-4.103058,"twenty":-16.260614,"median":-7.060036,"eighty":-4.807722,"marketCap":1639627035},{"date":"2023-02-03","current":-4.436015,"twenty":-16.246096,"median":-7.01344,"eighty":-4.774095,"marketCap":1772680414},{"date":"2023-02-10","current":-3.944263,"twenty":-16.246096,"median":-6.992631,"eighty":-4.723202,"marketCap":1576170807},{"date":"2023-02-17","current":-3.263875,"twenty":-16.20254,"median":-6.972926,"eighty":-4.700167,"marketCap":1304280300},{"date":"2023-02-24","current":-2.744622,"twenty":-16.179311,"median":-6.930371,"eighty":-4.643749,"marketCap":1096781161},{"date":"2023-03-03","current":-2.071586,"twenty":-16.103815,"median":-6.916165,"eighty":-4.599676,"marketCap":862954454},{"date":"2023-03-10","current":-1.506608,"twenty":-16.00509,"median":-6.874287,"eighty":-4.558953,"marketCap":627603239},{"date":"2023-03-17","current":-1.47522,"twenty":-15.92669,"median":-6.834504,"eighty":-4.549413,"marketCap":614528172},{"date":"2023-03-24","current":-1.715859,"twenty":-15.83087,"median":-6.818856,"eighty":-4.528078,"marketCap":714770356},{"date":"2023-03-31","current":-1.904185,"twenty":-15.764085,"median":-6.77547,"eighty":-4.472149,"marketCap":793220761},{"date":"2023-04-06","current":-1.747247,"twenty":-15.735048,"median":-6.723836,"eighty":-4.436015,"marketCap":727845423},{"date":"2023-04-14","current":-2.040199,"twenty":-15.706011,"median":-6.666466,"eighty":-4.416832,"marketCap":849879386},{"date":"2023-04-21","current":-2.395925,"twenty":-15.659552,"median":-6.614841,"eighty":-4.355216,"marketCap":998063485},{"date":"2023-04-28","current":-2.74119,"twenty":-15.446725,"median":-6.58279,"eighty":-4.322356,"marketCap":1141889227},{"date":"2023-05-05","current":-4.049823,"twenty":-15.148947,"median":-6.528777,"eighty":-4.251253,"marketCap":1687022412},{"date":"2023-05-12","current":-2.827879,"twenty":-14.894474,"median":-6.446532,"eighty":-4.251253,"marketCap":1216225460},{"date":"2023-05-19","current":-2.848552,"twenty":-14.785414,"median":-6.425509,"eighty":-4.211866,"marketCap":1225116526},{"date":"2023-05-26","current":-2.412652,"twenty":-14.775027,"median":-6.304447,"eighty":-4.183901,"marketCap":1037643179},{"date":"2023-06-02","current":-2.980335,"twenty":-14.743867,"median":-6.220771,"eighty":-4.163477,"marketCap":1281794515},{"date":"2023-06-09","current":-3.00061,"twenty":-14.691934,"median":-6.20437,"eighty":-4.099937,"marketCap":1290514205},{"date":"2023-06-16","current":-2.828277,"twenty":-14.663371,"median":-6.161604,"eighty":-4.047956,"marketCap":1216396835},{"date":"2023-06-23","current":-2.848552,"twenty":-14.629614,"median":-6.160667,"eighty":-4.037989,"marketCap":1225116526},{"date":"2023-06-30","current":-2.757317,"twenty":-14.619227,"median":-6.081286,"eighty":-4.011813,"marketCap":1185877918},{"date":"2023-07-07","current":-2.666082,"twenty":-14.608841,"median":-5.999743,"eighty":-3.955281,"marketCap":1146639311},{"date":"2023-07-14","current":-2.737043,"twenty":-14.294644,"median":-5.978661,"eighty":-3.888941,"marketCap":1177158228},{"date":"2023-07-21","current":-2.929649,"twenty":-14.164811,"median":-5.925278,"eighty":-3.838093,"marketCap":1259995288},{"date":"2023-07-28","current":-2.440896,"twenty":-14.110281,"median":-5.880833,"eighty":-3.745076,"marketCap":1049790412},{"date":"2023-08-04","current":-2.215663,"twenty":-13.954481,"median":-5.850813,"eighty":-3.591016,"marketCap":952921339},{"date":"2023-08-11","current":-1.672224,"twenty":-13.907741,"median":-5.850471,"eighty":-3.495033,"marketCap":791589180},{"date":"2023-08-18","current":-1.773425,"twenty":-13.863598,"median":-5.829313,"eighty":-3.350979,"marketCap":839495153},{"date":"2023-08-25","current":-1.542109,"twenty":-13.448131,"median":-5.794432,"eighty":-3.263843,"marketCap":729995785},{"date":"2023-09-01","current":-1.551747,"twenty":-13.326088,"median":-5.786986,"eighty":-3.202997,"marketCap":734558259},{"date":"2023-09-08","current":-1.262602,"twenty":-13.258575,"median":-5.744434,"eighty":-3.122256,"marketCap":597684049},{"date":"2023-09-15","current":-1.628852,"twenty":-13.217028,"median":-5.733797,"eighty":-3.041158,"marketCap":771058048},{"date":"2023-09-20","current":-2.524396,"twenty":-13.217028,"median":-5.729693,"eighty":-3.010747,"marketCap":1194985822},{"date":"2023-09-27","current":-2.073107,"twenty":-13.217028,"median":-5.725588,"eighty":-3.00872,"marketCap":981357072},{"date":"2023-10-06","current":-2.08721,"twenty":-13.154708,"median":-5.689852,"eighty":-2.968226,"marketCap":988032970},{"date":"2023-10-13","current":-1.805154,"twenty":-13.076808,"median":-5.652718,"eighty":-2.907056,"marketCap":854515001},{"date":"2023-10-20","current":-1.769898,"twenty":-13.019681,"median":-5.614721,"eighty":-2.88513,"marketCap":837825255},{"date":"2023-10-27","current":-2.891068,"twenty":-13.004101,"median":-5.607928,"eighty":-2.881778,"marketCap":1368559182},{"date":"2023-11-03","current":-5.218025,"twenty":-12.985925,"median":-5.542315,"eighty":-2.887777,"marketCap":2470082426},{"date":"2023-11-10","current":-4.147474,"twenty":-12.983328,"median":-5.514979,"eighty":-2.890675,"marketCap":1899621771},{"date":"2023-11-17","current":-5.962449,"twenty":-12.931394,"median":-5.510402,"eighty":-2.897604,"marketCap":2730914955},{"date":"2023-11-24","current":-6.006183,"twenty":-12.887251,"median":-5.519557,"eighty":-2.901841,"marketCap":2750946116},{"date":"2023-12-01","current":-5.364746,"twenty":-12.850898,"median":-5.531678,"eighty":-2.907056,"marketCap":2457155754},{"date":"2023-12-08","current":-5.044028,"twenty":-12.801561,"median":-5.510527,"eighty":-2.921539,"marketCap":2310260573},{"date":"2023-12-15","current":-5.933293,"twenty":-12.721065,"median":-5.510464,"eighty":-2.929922,"marketCap":2717560847},{"date":"2023-12-22","current":-5.947871,"twenty":-12.669131,"median":-5.52104,"eighty":-2.958695,"marketCap":2724237901},{"date":"2023-12-29","current":-7.595198,"twenty":-12.656148,"median":-5.567998,"eighty":-2.977756,"marketCap":3478744967},{"date":"2024-01-05","current":-7.068919,"twenty":-12.648358,"median":-5.606143,"eighty":-2.977756,"marketCap":3237699159},{"date":"2024-01-12","current":-5.810271,"twenty":-12.645761,"median":-5.634212,"eighty":-2.979819,"marketCap":2661214423},{"date":"2024-01-19","current":-5.312666,"twenty":-12.614601,"median":-5.614721,"eighty":-2.9925,"marketCap":2433301853},{"date":"2024-01-26","current":-4.829696,"twenty":-12.547088,"median":-5.593682,"eighty":-3.006692,"marketCap":2212092593},{"date":"2024-02-02","current":-5.341937,"twenty":-12.492558,"median":-5.520298,"eighty":-3.010747,"marketCap":2446708474},{"date":"2024-02-09","current":-6.307876,"twenty":-12.453608,"median":-5.593682,"eighty":-3.022911,"marketCap":2889126993},{"date":"2024-02-16","current":-6.995742,"twenty":-12.430238,"median":-5.614721,"eighty":-3.061433,"marketCap":3204182605},{"date":"2024-02-23","current":-7.668972,"twenty":-12.409465,"median":-5.641669,"eighty":-3.085762,"marketCap":3512534906},{"date":"2024-03-01","current":-6.922564,"twenty":-12.287422,"median":-5.656743,"eighty":-3.112118,"marketCap":3170666050},{"date":"2024-03-08","current":-7.390899,"twenty":-12.134218,"median":-5.701187,"eighty":-3.15467,"marketCap":3385171999},{"date":"2024-03-15","current":-7.186002,"twenty":-12.105655,"median":-5.729199,"eighty":-3.181485,"marketCap":3291325646},{"date":"2024-03-22","current":-7.130168,"twenty":-12.048528,"median":-5.739116,"eighty":-3.198694,"marketCap":4158285555},{"date":"2024-03-28","current":-6.309679,"twenty":-11.988805,"median":-5.767761,"eighty":-3.208741,"marketCap":3679779437},{"date":"2024-04-05","current":-6.52398,"twenty":-11.905712,"median":-5.794432,"eighty":-3.223115,"marketCap":3804759169},{"date":"2024-04-12","current":-7.034754,"twenty":-11.887535,"median":-5.799755,"eighty":-3.231235,"marketCap":4102640670},{"date":"2024-04-19","current":-5.699776,"twenty":-11.770685,"median":-5.80209,"eighty":-3.263749,"marketCap":3324086748},{"date":"2024-04-26","current":-5.931946,"twenty":-11.562952,"median":-5.80618,"eighty":-3.265036,"marketCap":3459487430},{"date":"2024-05-03","current":-10.41283,"twenty":-11.425329,"median":-5.840175,"eighty":-3.270608,"marketCap":6072720596},{"date":"2024-05-10","current":-9.356456,"twenty":-11.350025,"median":-5.850813,"eighty":-3.286479,"marketCap":5456647492},{"date":"2024-05-17","current":-8.918454,"twenty":-11.246158,"median":-5.860048,"eighty":-3.339097,"marketCap":5359651697},{"date":"2024-05-24","current":-7.687132,"twenty":-11.176049,"median":-5.894887,"eighty":-3.365852,"marketCap":4619673979},{"date":"2024-05-31","current":-7.387932,"twenty":-11.061795,"median":-5.906656,"eighty":-3.409503,"marketCap":4439866309},{"date":"2024-06-07","current":-7.019686,"twenty":-11.061795,"median":-5.916768,"eighty":-3.42283,"marketCap":4218564562},{"date":"2024-06-14","current":-6.858578,"twenty":-10.970912,"median":-5.931853,"eighty":-3.452525,"marketCap":4121745047},{"date":"2024-06-21","current":-8.354577,"twenty":-10.918979,"median":-5.932619,"eighty":-3.488495,"marketCap":5020783396},{"date":"2024-06-28","current":-7.272855,"twenty":-10.802129,"median":-5.962449,"eighty":-3.504025,"marketCap":4370709513},{"date":"2024-07-05","current":-7.318886,"twenty":-10.776162,"median":-5.967829,"eighty":-3.525405,"marketCap":4398372231},{"date":"2024-07-12","current":-7.618086,"twenty":-10.752792,"median":-5.996487,"eighty":-3.551476,"marketCap":4578179901},{"date":"2024-07-19","current":-6.662948,"twenty":-10.674892,"median":-6.006183,"eighty":-3.575448,"marketCap":4004178494},{"date":"2024-07-26","current":-6.45581,"twenty":-10.626408,"median":-6.059073,"eighty":-3.589685,"marketCap":3879696261},{"date":"2024-08-02","current":-5.385595,"twenty":-10.558611,"median":-6.059073,"eighty":-3.624614,"marketCap":3236538057},{"date":"2024-08-09","current":-5.224488,"twenty":-10.468227,"median":-6.006183,"eighty":-3.665485,"marketCap":3139718542},{"date":"2024-08-16","current":-4.673493,"twenty":-10.422117,"median":-5.993231,"eighty":-3.697751,"marketCap":2793099006},{"date":"2024-08-23","current":-4.953203,"twenty":-10.365969,"median":-5.965139,"eighty":-3.736471,"marketCap":2960267026},{"date":"2024-08-30","current":-4.603565,"twenty":-10.233459,"median":-5.947871,"eighty":-3.760134,"marketCap":2751307001},{"date":"2024-09-06","current":-3.939253,"twenty":-10.160753,"median":-5.931946,"eighty":-3.782425,"marketCap":2354282952},{"date":"2024-09-13","current":-4.172345,"twenty":-10.142576,"median":-5.929108,"eighty":-3.818273,"marketCap":2493589636},{"date":"2024-09-20","current":-4.102418,"twenty":-10.121803,"median":-5.916768,"eighty":-3.834832,"marketCap":2451797631},{"date":"2024-09-27","current":-4.580256,"twenty":-10.04086,"median":-5.906656,"eighty":-3.844026,"marketCap":2737376332},{"date":"2024-10-04","current":-3.997526,"twenty":-9.924144,"median":-5.889558,"eighty":-3.85521,"marketCap":2389109623},{"date":"2024-10-11","current":-4.253927,"twenty":-9.81478,"median":-5.85543,"eighty":-3.85521,"marketCap":2542346975},{"date":"2024-10-18","current":-4.137381,"twenty":-9.635322,"median":-5.850813,"eighty":-3.865113,"marketCap":2472693633},{"date":"2024-10-25","current":-6.200245,"twenty":-9.58521,"median":-5.845152,"eighty":-3.869326,"marketCap":3705557783},{"date":"2024-11-01","current":-6.153627,"twenty":-9.545653,"median":-5.850813,"eighty":-3.870615,"marketCap":3677696447},{"date":"2024-11-08","current":-6.49161,"twenty":-9.438984,"median":-5.860749,"eighty":-3.880745,"marketCap":3879691138},{"date":"2024-11-15","current":-5.322907,"twenty":-9.351569,"median":-5.860048,"eighty":-3.906131,"marketCap":3128772519},{"date":"2024-11-22","current":-6.046063,"twenty":-9.335032,"median":-5.864845,"eighty":-3.925768,"marketCap":3553839609},{"date":"2024-11-29","current":-5.974933,"twenty":-9.312017,"median":-5.894887,"eighty":-3.928465,"marketCap":3512029731},{"date":"2024-12-06","current":-5.880093,"twenty":-9.273181,"median":-5.880093,"eighty":-3.940255,"marketCap":3456283228},{"date":"2024-12-13","current":-3.565148,"twenty":-9.252819,"median":-5.860749,"eighty":-3.925768,"marketCap":2095572488},{"date":"2024-12-20","current":-3.254595,"twenty":-9.201669,"median":-5.850813,"eighty":-3.869971,"marketCap":1913031330},{"date":"2024-12-27","current":-3.453349,"twenty":-9.193937,"median":-5.850129,"eighty":-3.85048,"marketCap":2029857671},{"date":"2025-01-03","current":-3.490615,"twenty":-9.132765,"median":-5.829313,"eighty":-3.807761,"marketCap":2051762610},{"date":"2025-01-10","current":-3.006153,"twenty":-9.102707,"median":-5.80209,"eighty":-3.764435,"marketCap":1766998404},{"date":"2025-01-17","current":-3.652103,"twenty":-9.076891,"median":-5.794432,"eighty":-3.697751,"marketCap":2146684012},{"date":"2025-01-24","current":-3.937811,"twenty":-9.007127,"median":-5.786986,"eighty":-3.727867,"marketCap":2314621877},{"date":"2025-01-31","current":-4.285631,"twenty":-8.872423,"median":-5.773398,"eighty":-3.757982,"marketCap":2519067973},{"date":"2025-02-07","current":-4.173832,"twenty":-8.799234,"median":-5.739518,"eighty":-3.764435,"marketCap":2453353156},{"date":"2025-02-14","current":-4.496807,"twenty":-8.788101,"median":-5.733797,"eighty":-3.769191,"marketCap":2643195960},{"date":"2025-02-21","current":-4.248364,"twenty":-8.766864,"median":-5.725977,"eighty":-3.776324,"marketCap":2497163034},{"date":"2025-02-28","current":-4.086877,"twenty":-8.708072,"median":-5.711953,"eighty":-3.764434,"marketCap":2402241632},{"date":"2025-03-07","current":-6.190883,"twenty":-8.688152,"median":-5.725977,"eighty":-3.766814,"marketCap":2560326411},{"date":"2025-03-14","current":-5.922612,"twenty":-8.659753,"median":-5.733797,"eighty":-3.776324,"marketCap":2449378933},{"date":"2025-03-21","current":-5.592431,"twenty":-8.644987,"median":-5.733797,"eighty":-3.781293,"marketCap":2312828191},{"date":"2025-03-28","current":-6.479791,"twenty":-8.614572,"median":-5.734199,"eighty":-3.802816,"marketCap":2679808310},{"date":"2025-04-04","current":-5.840066,"twenty":-8.563776,"median":-5.744434,"eighty":-3.81273,"marketCap":2415241247},{"date":"2025-04-11","current":-5.61192,"twenty":-8.518871,"median":-5.734199,"eighty":-3.827124,"marketCap":2320887960},{"date":"2025-04-17","current":-5.27051,"twenty":-8.465345,"median":-5.734199,"eighty":-3.83157,"marketCap":2179693255},{"date":"2025-04-25","current":-5.569244,"twenty":-8.446639,"median":-5.734602,"eighty":-3.839724,"marketCap":2303238622},{"date":"2025-05-02","current":-5.420577,"twenty":-8.416128,"median":-5.731498,"eighty":-3.85048,"marketCap":2241755640},{"date":"2025-05-09","current":-4.417557,"twenty":-8.366085,"median":-5.725588,"eighty":-3.862304,"marketCap":1826942589},{"date":"2025-05-16","current":-6.127196,"twenty":-8.354577,"median":-5.719055,"eighty":-3.869326,"marketCap":2506641961},{"date":"2025-05-23","current":-5.782002,"twenty":-8.206955,"median":-5.725977,"eighty":-3.869326,"marketCap":2365422696},{"date":"2025-05-30","current":-5.609405,"twenty":-8.183889,"median":-5.717278,"eighty":-3.871904,"marketCap":2294813063},{"date":"2025-06-06","current":-6.256644,"twenty":-8.116751,"median":-5.727588,"eighty":-3.875071,"marketCap":2559599186},{"date":"2025-06-13","current":-6.882308,"twenty":-8.084074,"median":-5.733797,"eighty":-3.885639,"marketCap":2815559104},{"date":"2025-06-20","current":-6.127196,"twenty":-8.072361,"median":-5.736885,"eighty":-3.891073,"marketCap":2506641961},{"date":"2025-06-27","current":-6.019323,"twenty":-8.052684,"median":-5.739948,"eighty":-3.904996,"marketCap":2462510941},{"date":"2025-07-03","current":-5.8683,"twenty":-8.039651,"median":-5.739948,"eighty":-3.917936,"marketCap":2400727512},{"date":"2025-07-11","current":-6.19192,"twenty":-8.033134,"median":-5.744434,"eighty":-3.925541,"marketCap":2533120573},{"date":"2025-07-18","current":-6.105621,"twenty":-8.01579,"median":-5.760427,"eighty":-3.925768,"marketCap":2497815757},{"date":"2025-07-25","current":-6.493965,"twenty":-7.990725,"median":-5.779325,"eighty":-3.930585,"marketCap":2656687431},{"date":"2025-08-01","current":-5.31076,"twenty":-7.981068,"median":-5.766913,"eighty":-3.937811,"marketCap":2172637129},{"date":"2025-08-08","current":-5.786184,"twenty":-7.971528,"median":-5.760427,"eighty":-3.938388,"marketCap":2124061909},{"date":"2025-08-15","current":-6.978197,"twenty":-7.946096,"median":-5.780664,"eighty":-3.941257,"marketCap":2561640196},{"date":"2025-08-22","current":-5.767956,"twenty":-7.910019,"median":-5.782002,"eighty":-3.949772,"marketCap":2117370494},{"date":"2025-08-29","current":-5.999704,"twenty":-7.899359,"median":-5.786585,"eighty":-3.959846,"marketCap":2202443416},{"date":"2025-09-05","current":-6.154203,"twenty":-7.881311,"median":-5.790346,"eighty":-3.962582,"marketCap":2259158697},{"date":"2025-09-12","current":-6.669199,"twenty":-7.856728,"median":-5.794432,"eighty":-3.962656,"marketCap":2448209634},{"date":"2025-09-19","current":-7.338694,"twenty":-7.8463,"median":-5.798504,"eighty":-3.96514,"marketCap":2693975852},{"date":"2025-09-26","current":-6.334452,"twenty":-7.827426,"median":-5.810271,"eighty":-3.975773,"marketCap":2325326525},{"date":"2025-10-03","current":-6.437451,"twenty":-7.812412,"median":-5.822304,"eighty":-3.980017,"marketCap":2363136712},{"date":"2025-10-10","current":-6.282952,"twenty":-7.805489,"median":-5.840066,"eighty":-3.988203,"marketCap":2306421431},{"date":"2025-10-17","current":-6.5147,"twenty":-7.787822,"median":-5.846726,"eighty":-3.998005,"marketCap":2391494353},{"date":"2025-10-24","current":-6.412743,"twenty":-7.77464,"median":-5.850129,"eighty":-3.999922,"marketCap":2354066777},{"date":"2025-10-31","current":-6.332249,"twenty":-7.766384,"median":-5.850813,"eighty":-3.999922,"marketCap":2324517822},{"date":"2025-11-07","current":-5.98976,"twenty":-7.759994,"median":-5.860749,"eighty":-3.999922,"marketCap":2088126179},{"date":"2025-11-14","current":-5.650717,"twenty":-7.710147,"median":-5.861451,"eighty":-4.001057,"marketCap":1969930358},{"date":"2025-11-21","current":-5.707224,"twenty":-7.70248,"median":-5.864845,"eighty":-4.009181,"marketCap":1989629661},{"date":"2025-11-28","current":-6.667846,"twenty":-7.699299,"median":-5.8683,"eighty":-4.009181,"marketCap":2324517822},{"date":"2025-12-05","current":-6.498325,"twenty":-7.689406,"median":-5.870955,"eighty":-4.011287,"marketCap":2265419911},{"date":"2025-12-12","current":-6.187535,"twenty":-7.679723,"median":-5.876746,"eighty":-4.011813,"marketCap":2157073742},{"date":"2025-12-19","current":-5.904999,"twenty":-7.677871,"median":-5.881339,"eighty":-4.019031,"marketCap":2058577224},{"date":"2025-12-26","current":-6.046267,"twenty":-7.672532,"median":-5.881339,"eighty":-4.021875,"marketCap":2107825483},{"date":"2026-01-02","current":-5.59421,"twenty":-7.666027,"median":-5.881339,"eighty":-4.023447,"marketCap":1950231054},{"date":"2026-01-09","current":-6.328803,"twenty":-7.658701,"median":-5.881339,"eighty":-4.027856,"marketCap":2206322000},{"date":"2026-01-16","current":-11.160166,"twenty":-7.674311,"median":-5.891948,"eighty":-4.032863,"marketCap":3890612457},{"date":"2026-01-23","current":-20.738131,"twenty":-7.69623,"median":-5.904137,"eighty":-4.034031,"marketCap":7229644413},{"date":"2026-01-30","current":-16.697869,"twenty":-7.766384,"median":-5.907087,"eighty":-4.037989,"marketCap":5821144207},{"date":"2026-02-06","current":-15.935022,"twenty":-7.812412,"median":-5.912719,"eighty":-4.044079,"marketCap":5555203609},{"date":"2026-02-13","current":-18.703873,"twenty":-7.881311,"median":-5.922612,"eighty":-4.044605,"marketCap":6520469484},{"date":"2026-02-20","current":-24.326337,"twenty":-7.967511,"median":-5.925867,"eighty":-4.046711,"marketCap":8480550191},{"date":"2026-02-27","current":-27.941151,"twenty":-7.993654,"median":-5.931946,"eighty":-4.049823,"marketCap":9818464404},{"date":"2026-03-06","current":-26.214943,"twenty":-8.067442,"median":-5.932507,"eighty":-4.054835,"marketCap":9211878645},{"date":"2026-03-13","current":-22.87956,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":8039831585},{"date":"2026-03-20","current":-25.805335,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":9067943041},{"date":"2026-03-27","current":-21.592219,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":7587462545},{"date":"2026-04-02","current":-20.983634,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":7373606891},{"date":"2026-04-10","current":-21.982854,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":7724731028},{"date":"2026-04-17","current":-21.306911,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":7487205877},{"date":"2026-04-24","current":-24.069462,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":8457960845},{"date":"2026-05-01","current":-20.866078,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":7332298169},{"date":"2026-05-08","current":-9.378085,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":8013892083},{"date":"2026-05-15","current":-9.988994,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":8535934912},{"date":"2026-05-22","current":-9.48648,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":8106519781},{"date":"2026-05-29","current":-9.461967,"twenty":-8.07728,"median":-5.933024,"eighty":-4.055028,"marketCap":8085572702},{"date":"2026-06-05","current":-8.934941,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":7635210492},{"date":"2026-06-12","current":-8.824633,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":7540948634},{"date":"2026-06-18","current":-8.567248,"twenty":-8.092741,"median":-5.933024,"eighty":-4.055221,"marketCap":7321004299},{"date":"2026-06-26","current":-9.547762,"twenty":-8.07728,"median":-5.933024,"eighty":-4.055028,"marketCap":8158887480},{"date":"2026-07-02","current":-11.275919,"twenty":-8.07728,"median":-5.933024,"eighty":-4.055028,"marketCap":9635656588},{"date":"2026-07-10","current":-10.871457,"twenty":-8.07728,"median":-5.933024,"eighty":-4.055028,"marketCap":9290029775},{"date":"2026-07-17","current":-9.131044,"twenty":-8.07728,"median":-5.933024,"eighty":-4.055028,"marketCap":7802787128},{"date":"2026-07-24","current":-9.069761,"twenty":-8.07728,"median":-5.933024,"eighty":-4.055028,"marketCap":7750419429},{"date":"2026-07-31","current":-9.131044,"twenty":-8.067442,"median":-5.932507,"eighty":-4.054835,"marketCap":7802787128},{"date":"2026-08-07","current":-7.817753,"twenty":-7.993654,"median":-5.932507,"eighty":-4.054835,"marketCap":7758001518},{"date":"2026-08-14","current":-8.170192,"twenty":-7.993654,"median":-5.932507,"eighty":-4.054835,"marketCap":8107747488},{"date":"2026-08-21","current":-8.373112,"twenty":-7.993654,"median":-5.932507,"eighty":-4.054835,"marketCap":8309116380},{"date":"2026-08-28","current":-8.971192,"twenty":-7.993654,"median":-5.932507,"eighty":-4.054835,"marketCap":8902624693},{"date":"2026-09-04","current":-8.746912,"twenty":-7.993654,"median":-5.932507,"eighty":-4.054835,"marketCap":8680059075},{"date":"2026-09-11","current":-8.244952,"twenty":-7.993654,"median":-5.932507,"eighty":-4.054835,"marketCap":8181936027},{"date":"2026-09-18","current":-9.035271,"twenty":-7.993654,"median":-5.932507,"eighty":-4.054835,"marketCap":8966214869},{"date":"2026-09-25","current":-9.227511,"twenty":-7.993654,"median":-5.932507,"eighty":-4.054835,"marketCap":9156985398},{"date":"2026-10-02","current":-9.911031,"twenty":-7.993654,"median":-5.932507,"eighty":-4.054835,"marketCap":9835280613},{"date":"2026-10-07","current":-10.34891,"twenty":-7.993654,"median":-5.932507,"eighty":-4.054835,"marketCap":10269813485}],"updateTime":1791454422732},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBRX\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2637399319","title":"ImmunityBio survey shows UK NMIBC patients favor bladder-sparing therapy after BCG failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2637399319","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637399319?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:31","pubTimestamp":1779449487,"startTime":"0","endTime":"0","summary":"ImmunityBio highlighted UK patient survey findings on treatment preferences in BCG-unresponsive high-risk non-muscle-invasive bladder cancer, with results presented at ISPOR 2026 on May 17-20, 2026.The study found most respondents favored bladder-preserving approaches over radical cystectomy, with preferences varying by age and prior treatment experience.Cancer control outcomes such as recurrence risk, progression risk, and expected survival drove decision-making more than lifestyle considerations, although quality-of-life impacts remained a key trade-off for many patients.The findings point to a commercially relevant demand signal for bladder-sparing options, while reinforcing that uptake will depend on how individual patients weigh effectiveness against day-to-day disruption.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL5MMx0L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637031938","title":"ImmunityBio says ANKTIVA plus BCG shows lower cost per sustained responder vs TAR-200","url":"https://stock-news.laohu8.com/highlight/detail?id=2637031938","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637031938?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:30","pubTimestamp":1779449437,"startTime":"0","endTime":"0","summary":"ImmunityBio reported preliminary results from a health economic analysis that were presented at ISPOR 2026 on May 17-20.The analysis found ANKTIVA with BCG delivered better economic value than TAR-200 in BCG-unresponsive non-muscle-invasive bladder cancer carcinoma in situ, driven by a higher rate of durable responses and fewer bladder removals.Across a three-year Medicare-based model, ANKTIVA with BCG showed lower costs per sustained responder, lower costs tied to avoiding cystectomy, and lower costs per cystectomy-free time than TAR-200.The cost advantage was attributed mainly to lower treatment acquisition and administration costs in the model.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDLc1LZ19:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637358178","title":"Is ANKTIVA’s BCG Tie-Up And New Patents Altering The Investment Case For ImmunityBio (IBRX)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2637358178","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637358178?lang=en_us&edition=fundamental","pubTime":"2026-05-21 23:48","pubTimestamp":1779378516,"startTime":"0","endTime":"0","summary":"In recent weeks, ImmunityBio reported new indirect comparison data suggesting ANKTIVA plus BCG may offer stronger responses and fewer side effects than other approved bladder cancer therapies, alongside FDA acceptance of a supplemental Biologics License Application and exclusive U.S. rights to develop and supply the Tokyo-172 BCG strain.\nThese developments, combined with fresh U.S. patents protecting the ANKTIVA plus BCG franchise through at least 2035, deepen ImmunityBio’s integration...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ibrx/immunitybio/news/is-anktivas-bcg-tie-up-and-new-patents-altering-the-investme","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ibrx/immunitybio/news/is-anktivas-bcg-tie-up-and-new-patents-altering-the-investme","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","AIPO","BCG","IBRX","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129274191","title":"Movement Alert｜ImmunityBio Falls 7.89% in Regular Trading, Profit-Taking Emerges After Multiple Catalysts Priced In","url":"https://stock-news.laohu8.com/highlight/detail?id=1129274191","media":"Market Focus","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129274191?lang=en_us&edition=fundamental","pubTime":"2026-05-21 23:02","pubTimestamp":1779375776,"startTime":"0","endTime":"0","summary":"On May 21, ImmunityBio fell 7.89% in regular trading, trading at $7.345/share, with trading volume of $54.27 million. The decline comes as the stock experiences a pullback following a concentrated...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637396473","title":"ImmunityBio faces securities class action after FDA flags misleading Anktiva cancer claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2637396473","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637396473?lang=en_us&edition=fundamental","pubTime":"2026-05-21 21:07","pubTimestamp":1779368866,"startTime":"0","endTime":"0","summary":"ImmunityBio faces a securities class action tied to investor purchases from Jan. 19, 2026 to Mar. 24, 2026.The case follows an FDA warning letter flagging what it called false or misleading promotional claims that Anktiva could cure, prevent, or treat cancers beyond its approved bladder cancer use.Shares fell more than 21% on Mar. 24, 2026, wiping out nearly USD 2 billion in market value.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDLc9c34M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"ImmunityBio faces securities class action after FDA flags misleading Anktiva cancer claims","news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180096844","title":"Movement Alert｜ImmunityBio Rises 5.03% in Regular Trading, Positive Clinical Data and Patent Grants Fuel Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1180096844","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180096844?lang=en_us&edition=fundamental","pubTime":"2026-05-21 03:34","pubTimestamp":1779305651,"startTime":"0","endTime":"0","summary":"On May 21, ImmunityBio rose 5.03% in regular trading, trading at $8.15/share, with trading volume of $180 million. The stock continues to gain momentum following a series of positive developments...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636826375","title":"Mink Therapeutics starts Phase 2 trial of agenT-797 in severe acute lung injury","url":"https://stock-news.laohu8.com/highlight/detail?id=2636826375","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636826375?lang=en_us&edition=fundamental","pubTime":"2026-05-20 23:07","pubTimestamp":1779289655,"startTime":"0","endTime":"0","summary":"Mink Therapeutics reported new clinical and translational data on its investigational allo-iNKT cell therapy agenT-797 at the American Thoracic Society International Conference 2026, with the case study also published in Clinical Immunology Communications.The sequential regimen pairing agenT-797 with ImmunityBio’s IL-15 superagonist N-803 was linked to pathogen suppression, signs of lung immune recovery, reduced inflammatory signaling, and activation of tissue repair pathways in a critically ill patient with disseminated Coccidioides infection, ARDS, and hospital-acquired Pseudomonas pneumonia.The patient later transitioned to comfort care due to recurrent cardiac decompensation, with investigators attributing the likely terminal mechanism to acute heart failure rather than cytokine release or infection.The update supports an ongoing randomized Phase 2 trial testing agenT-797 with standard of care versus placebo with standard of care in ICU patients with severe acute lung injury and ac","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDLc2537c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX","NDAQ","SG9999014013.SGD","SG9999014039.USD","SG9999014021.USD","IE00BKPKM429.USD","LU2095319765.USD","IE00BGHQF748.EUR","BK4585","BK4139","LU2210150020.SGD","BK4112","IE00B3QW5Z07.USD","BK4588","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014005.SGD","LU0314104364.USD","INKT","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636841505","title":"S&P 500 Futures Rise In Premarket Trading; Immunovant, ImmunityBio Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=2636841505","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636841505?lang=en_us&edition=fundamental","pubTime":"2026-05-20 19:30","pubTimestamp":1779276600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Barrons.com using technology from Automated Insights.With U.S. stock markets set to open in two hours, Immunovant Inc.  was up 22.7% in pre-market trading, and ImmunityBio Inc.  was up 9.3%.Roivant Sciences Ltd. , CAVA Group Inc. , and Boyd Gaming Corp.  were all posting gains of at least 7%. In early trading, Viavi Solutions Inc.  and Old National Bancorp  had posted declines, falling 5.5% and 4.9%, respectively.Meanwhile S&P 500 futures were up 0.32%, with futures for the Dow Jones Industrial Average rising 0.17%. The Cboe Volatility Index futures were up 0.30%.In commodities news, Brent crude oil futures were down 2.18%, while gold futures were down 0.36%. Bitcoin rose 0.86% to $77,415.In the previous regular trading session, the S&P 500 and the Dow were down 0.67% and 0.65%, respectively. Stocks in Asia were down overnight, with Japan's NIKKEI 225 Index down 1.23% and China's Shanghai Composite Index falling 0.18%.In afternoon trading, st","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPA","BK4550","SPMO","LU2065171402.SGD","LU2065169927.USD","IVW","SPDN","VTI","IVV","SPYD","LU2065170008.USD","BK4588","SSO","VV","LU0757428866.USD","BK4504","SH","SPUU","LU1815336091.USD","VIAV","BK4585","SPYU","BK4581","XLG","JEPI","BMAY","BK4534","SPXL","BK4139","SMAX","SPYV","BK4559","SFY","CAVA","ITOT","GPIX","SPLV","YSPY","LU0240878834.USD","MMAX","SPYQ","XDTE","SPYI","DMAX","RSPN","MESmain","GSLC","SCHX","LU0240877869.USD","OEF","ALLW","LU0205193047.USD","LU0205194284.USD","XYLD","SPUS","LU1559883803.SGD","OEX","SPYM","BYD",".SPX","VBK","MOAT","IMVT","SPYG","VTV","HIBL","ROIV","ETFT","SPYB","TSPY","SPGP","BK4150","VEU","BK4020","UPRO","IJR","ACWI","IVE","NOBL","IBRX","SPHQ","RSPU","ESmain","BK4211","SPYH","DBSC","BK4209","SPXS","SCHB","HIBS","IJH","BK4007","SDS","SPHD","LU2065171311.SGD","RSP","LU0566484027.USD","SPXU","ONB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636492138","title":"ImmunityBio Price Target Maintained With a $15.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2636492138","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636492138?lang=en_us&edition=fundamental","pubTime":"2026-05-20 19:17","pubTimestamp":1779275820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IBRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 20, 2026 07:17 ET (11:17 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636109568","title":"ImmunityBio's Supplemental Biologics License Application for Anktiva Accepted by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2636109568","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636109568?lang=en_us&edition=fundamental","pubTime":"2026-05-20 17:28","pubTimestamp":1779269305,"startTime":"0","endTime":"0","summary":"ImmunityBio's  supplemental biologics license application for Anktiva in combination with Bacillus Calmette-Guerin in patients with bladder cancer with papillary disease has been accepted for review by the US Food and Drug Administration, the company said late Tuesday.The filing was supported by results from a phase 2/3 trial, which met its primary endpoint with a 12-month disease-free survival rate of 58.2%, ImmunityBio said.The regulator has set a Prescription Drug User Fee Act target action date of Jan. 6, 2027, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4588","BK4585","LABU","IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636589955","title":"ImmunityBio announces FDA acceptance of supplemental BLA for ANKTIVA","url":"https://stock-news.laohu8.com/highlight/detail?id=2636589955","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636589955?lang=en_us&edition=fundamental","pubTime":"2026-05-20 09:35","pubTimestamp":1779240907,"startTime":"0","endTime":"0","summary":"ImmunityBio (IBRX) “announced that the U.S. Food and Drug Administration has accepted for review the supplemental Biologics License Application for...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immunitybio-announces-fda-acceptance-of-supplemental-bla-for-anktiva-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immunitybio-announces-fda-acceptance-of-supplemental-bla-for-anktiva-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BK4139","IBRX","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636953578","title":"FDA accepts ImmunityBio sBLA for ANKTIVA plus BCG in papillary NMIBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2636953578","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636953578?lang=en_us&edition=fundamental","pubTime":"2026-05-20 08:32","pubTimestamp":1779237177,"startTime":"0","endTime":"0","summary":"ImmunityBio secured FDA acceptance for review of a supplemental BLA seeking to expand ANKTIVA with BCG into BCG-unresponsive non-muscle invasive bladder cancer with papillary-only disease.The FDA set a PDUFA target action date of Jan. 6, 2027.The filing is supported by QUILT-3.032 Cohort B data in 80 patients, including 12-month disease-free survival of 58.2%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunitybio Inc. published the original content used to generate this news brief on May 19, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDLxkkwl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636359895","title":"Immunitybio Announces FDA Acceptance of Supplemental Bla for Anktiva® Plus Bcg in Bcg-Unresponsive Non-Muscle Invasive Bladder Cancer With Papillary Disease; Pdufa Date Set for January 6, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2636359895","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636359895?lang=en_us&edition=fundamental","pubTime":"2026-05-20 08:30","pubTimestamp":1779237000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUA4MTF95:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636853126","title":"Immunitybio Presents Favorable Comparative Effectiveness Data in Complete Response Rates of Nai + Bcg Versus Nadofaragene and Tar-200 at Aua 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2636853126","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636853126?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:30","pubTimestamp":1779190200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUA5SM7V9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636853625","title":"ImmunityBio reports higher complete response rates for ANKTIVA plus BCG in AUA analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2636853625","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636853625?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:26","pubTimestamp":1779189969,"startTime":"0","endTime":"0","summary":"ImmunityBio presented indirect comparative analyses at the AUA 2026 meeting comparing ANKTIVA with BCG against nadofaragene firadenovec-vncg or TAR-200 in BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ.The analyses indicated ANKTIVA with BCG produced more frequent complete responses with longer-lasting benefit than nadofaragene, supporting a stronger bladder-preservation profile.Against TAR-200, ANKTIVA with BCG delivered broadly similar response outcomes while showing a cleaner treatment-related safety profile.The data were generated from unanchored, population-adjusted cross-trial comparisons rather than head-to-head randomized studies, a factor that can influence how investors and clinicians weigh the results.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL8QGg6x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636076145","title":"Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday Amid Stalled Iran Peace Efforts, Inflation Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2636076145","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636076145?lang=en_us&edition=fundamental","pubTime":"2026-05-18 21:12","pubTimestamp":1779109942,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.1%, and the actively traded Invesco QQQ Trust (QQQ) was 0.03% lower in Monday's premarket activity as stalled diplomatic e","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BITO","UNG","MFG.AU","EQR","NEE","RYAAY","EEM","XLY","IBRX","QQQ","RAMP","FAS","PMR","IVV","XRT","VIS","D","IYH","IYE","EETH","BETH","FDN","IYJ","XLV","SPY","XLF","SLV","SPY.AU","IGM","XLI","SOXX","XSD","XLE","FAZ","VDC","IBB","IYK","RTH","VHT","USO","EXI","MFG","XLP","VHT.AU","F","XLK","IYW","GLD","IWM","RTH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636076817","title":"BRIEF-Immunitybio Announces Comprehensive U.S. Patents Covering Combination Of Anktiva With Bcg For Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2636076817","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636076817?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:56","pubTimestamp":1779108975,"startTime":"0","endTime":"0","summary":"BRIEF-Immunitybio Announces Comprehensive U.S. Patents Covering Combination Of Anktiva With Bcg For Cancer TreatmentMay 18 (Reuters) - Immunitybio Inc IBRX.O:IMMUNITYBIO ANNOUNCES COMPREHENSIVE U.S. P","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nTUA3WDQCY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636607356","title":"ImmunityBio Secures Five US Patents for Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2636607356","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636607356?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:09","pubTimestamp":1779106153,"startTime":"0","endTime":"0","summary":"ImmunityBio  said Monday that it has received five United States patents covering the combination of its IL-15 receptor agonist ANKTIVA with Bacillus Calmette-Guerin, or BCG, to treat cancer.The patents, which have validity until at least 2035, protect the ANKTIVA plus BCG product, the specific intravesical dosing regimen, the two-vial commercial kit, and methods of treating non-muscle invasive bladder cancer, including BCG-naive disease and bladder cancer, the company said.The company said that the patents support its pending supplemental biologics license application for BCG-unresponsive papillary-only disease, and to advance a registrational trial evaluating ANKTIVA in combination with BCG compared with BCG alone in BCG-naive non-muscle invasive bladder cancer carcinoma in situ.Shares of the company were up nearly 4% in Monday's premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636202080","title":"ImmunityBio wins five US patents for ANKTIVA-BCG cancer treatment combo through 2035","url":"https://stock-news.laohu8.com/highlight/detail?id=2636202080","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636202080?lang=en_us&edition=fundamental","pubTime":"2026-05-18 19:30","pubTimestamp":1779103841,"startTime":"0","endTime":"0","summary":"ImmunityBio disclosed the issuance of five U.S. patents covering the combination of its IL-15 receptor agonist ANKTIVA  with BCG for cancer treatment, with terms running through at least 2035.The patents cover the approved ANKTIVA-BCG product in non-muscle invasive bladder cancer, including intravesical dosing, a two-vial commercial kit, and related treatment methods.The company said the estate supports its commercial position in BCG-unresponsive NMIBC, a pending supplemental BLA for BCG-unresponsive papillary-only disease, and a registrational study in BCG-naive NMIBC carcinoma in situ.ImmunityBio also said the patents extend to combinations using any approved BCG strain, alongside its exclusive U.S. development and supply agreement for Tokyo-172 BCG.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and shou","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDLbBd2Fc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636202520","title":"Immunitybio Inc - Patents Cover Anktiva Plus Bcg for Bladder Cancer With Terms Through at Least 2035","url":"https://stock-news.laohu8.com/highlight/detail?id=2636202520","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636202520?lang=en_us&edition=fundamental","pubTime":"2026-05-18 19:30","pubTimestamp":1779103800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nTUA3WDQCY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":110,"code":"91000000","status":"200"}]}}